PreciThera
Montréal
About PreciThera
PreciThera, Inc. is a biotechnology company committed to the development of therapies for rare bone diseases using the combined application of computational technology and a deep understanding of disease pathology. The company focuses on heterogeneous genetic disorders that primarily manifest in bone dysfunction. In depth understanding of disease mechanism will allow PreciThera’s targeted strategies to meaningfully impact both the skeletal symptoms as well as the extraskeletal issues found in these patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $28.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2017)
- Website: precithera.com
- Phone: (514)700-0764
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/precithera-113656 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.